On Friday, Agenus Inc (NASDAQ: AGEN) was 11.04% up from the session before settling in for the closing price of $1.67. A 52-week range for AGEN has been $1.67 – $19.69.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 33.20%. When this article was written, the company’s average yearly earnings per share was at 51.84%. With a float of $22.89 million, this company’s outstanding shares have now reached $23.46 million.
Considering the fact that the conglomerate employs 389 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 68.67%, operating margin of -61.67%, and the pretax margin is -145.41%.
Agenus Inc (AGEN) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Agenus Inc stocks. The insider ownership of Agenus Inc is 2.44%, while institutional ownership is 35.14%.
Agenus Inc (AGEN) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.23 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 51.84% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 43.40% during the next five years compared to 7.90% growth over the previous five years of trading.
Agenus Inc (NASDAQ: AGEN) Trading Performance Indicators
You can see what Agenus Inc (AGEN) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 0.19. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.42.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -10.69, a number that is poised to hit -1.75 in the next quarter and is forecasted to reach -2.65 in one year’s time.
Technical Analysis of Agenus Inc (AGEN)
Compared to the last year’s volume of 0.42 million, its volume of 0.62 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 7.88%. Additionally, its Average True Range was 0.25.
During the past 100 days, Agenus Inc’s (AGEN) raw stochastic average was set at 6.95%, which indicates a significant decrease from 12.53% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 90.98% in the past 14 days, which was lower than the 92.42% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.1451, while its 200-day Moving Average is $6.1483. Nevertheless, the first resistance level for the watch stands at $1.9631 in the near term. At $2.0661, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.2223. If the price goes on to break the first support level at $1.7039, it is likely to go to the next support level at $1.5477. Should the price break the second support level, the third support level stands at $1.4447.
Agenus Inc (NASDAQ: AGEN) Key Stats
There are 23,459K outstanding shares of the company, which has a market capitalization of 43.63 million. As of now, sales total 156,310 K while income totals -245,760 K. Its latest quarter income was 25,110 K while its last quarter net income were -66,390 K.
